Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

118.37
-1.3000-1.09%
Pre-market: 118.14-0.2300-0.19%05:10 EDT
Volume:2.50M
Turnover:297.00M
Market Cap:231.92B
PE:18.56
High:119.55
Open:118.18
Low:117.80
Close:119.67
Loading ...

Retirement of Well-Regarded Executive a Loss for Novartis -- Market Talk

Dow Jones
·
1 hour ago

Novartis AG Reports 12% Revenue Increase, 24% Rise in Net Income, and 29% Gain in EPS for Q2 2025

Reuters
·
4 hours ago

Novartis Names Mukul Mehta as Finance Chief

MT Newswires Live
·
32 mins ago

MP Materials Drops After $500M Stock Offering Announcement; Sarepta Soars on Restructuring Plan

Tiger Newspress
·
41 mins ago

Novartis Tweaks Full-Year 2025 Guidance: Core Operating Income Now Expected To Grow In Low-Teens, Sales Still Seen Growing High Single Digits

Benzinga
·
3 hours ago

Novartis Q2 Adj. EPS $2.42 Beats $2.38 Estimate, Sales $14.05B Miss $14.06B Estimate

Benzinga
·
4 hours ago

Is NVS Stock (NVS) a Buy Ahead of Q2 Earnings?

TIPRANKS
·
9 hours ago

Novartis AG Falls Wednesday, Underperforms Market

Dow Jones
·
16 hours ago

Market Chatter: Judge Denies Novartis' Request to Block Generic Version of Entresto

MT Newswires Live
·
Yesterday

Judge Denies Novartis' Request to Block Generic Version of Entresto, Reuters Reports

MT Newswires Live
·
Yesterday

Novartis's U.S. Business in Focus Amid Threats From Tariffs, Drug Prices -- Earnings Preview

Dow Jones
·
15 Jul

Novartis AG expected to post earnings of $2.36 a share - Earnings Preview

Reuters
·
15 Jul

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Jul

Novartis Loses Patent Infringement Suit Against MSN Pharmaceuticals for Entresto Generic

MT Newswires Live
·
12 Jul

Novartis loses bid to block MSN generic of Entresto, Bloomberg says

TIPRANKS
·
11 Jul

Market Chatter: FDA May Fast Track Drug Reviews for Lower US Prices

MT Newswires Live
·
11 Jul

FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports

MT Newswires Live
·
11 Jul

Novartis AG Rises Thursday, Outperforms Market

Dow Jones
·
11 Jul

Big Pharma on the Clock as 200% Tariffs Loom

GuruFocus.com
·
10 Jul

Berenberg Bank Sticks to Their Hold Rating for Novartis (NVS)

TIPRANKS
·
10 Jul